Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07350304
Eligibility Criteria:
Inclusion Criteria:
* Male or female patients at least 18 years of age
* A diagnosis of mild, moderate or severe glaucoma.
* Optic nerve appearance characteristic of glaucoma.
* \< +/- 6D Spherical equivalent Refractive Error
* BCVA ≥ 20/40
* Previous Zeiss OCT RNFL with signal strength of ≥ 7/10
* The subject is able to understand the requirements of the study and provide written informed consent.
* Subject is willing to follow study instructions, agrees to comply with all study procedures and testing.
Exclusion Criteria:
* If pseudophakic, PCO must be ≤ trace
* If phakic, the cataract must be ≤ 1+
* No diagnosis of optic nerve disease other than glaucoma, and no macular disease.
* Current participation or participation in any drug or device clinical trial (which includes the fellow eye) within the past 30 calendar days.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07350304
Study Brief:
Protocol Section:
NCT07350304